Kim Tsuchimoto
Fortune : 747 049 $ au 31/05/2026
Fortune : 747 049 $ au 31/05/2026
Ms. Kim R.
Tsuchimoto, CPA, is an Independent Director at Thiogenesis Therapeutics Corp.
She is on the Board of Directors at Thiogenesis Therapeutics Corp., Monopar Therapeutics, Inc. and Thiogenesis Therapeutics, Inc. /New/.
Ms. Tsuchimoto was previously employed as a Chief Financial Officer by Mercaptor Discoveries, Inc., a Treasurer, VP-International Finance & Tax by Horizon Pharmaceutical LLC, a VP-Financial Planning & Analysis, Internal Control by Raptor Pharmaceuticals Corp., a Chief Financial Officer, Secretary & Treasurer by Raptor Pharmaceutical, Inc., a Controller by International Microcomputer Software, Inc., a Controller & Assistant Vice President by SpatiaLight, Inc., a Vice President-Treasurer & Controller by BioMarin Pharmaceutical, Inc., and a Treasurer, Vice President & Controller by Glyko, Inc. She received her undergraduate degree from San Francisco State University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 11 486 ( 0,17% ) | 747 049 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/03/2023 |
| THIOGENESIS THERAPEUTICS, CORP. | Directeur/Membre du Conseil | 31/03/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
Mercaptor Discoveries, Inc.
Mercaptor Discoveries, Inc. Pharmaceuticals: MajorHealth Technology Engages in manufacturing drugs | Fondateur | 01/08/2019 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Directeur Financier/CFO | 01/05/2015 |
International Microcomputer Software, Inc.
International Microcomputer Software, Inc. Packaged SoftwareTechnology Services Develops software for productivity, utility, and digital image categories | Comptroller/Controller/Auditor | 01/03/2006 |
| SPATIALIGHT, INC. | Comptroller/Controller/Auditor | 23/08/2005 |
| BIOMARIN PHARMACEUTICAL INC. | Comptroller/Controller/Auditor | 01/06/2005 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
International Microcomputer Software, Inc.
International Microcomputer Software, Inc. Packaged SoftwareTechnology Services Develops software for productivity, utility, and digital image categories | Technology Services |
SpatiaLight, Inc.
SpatiaLight, Inc. Electronics/AppliancesConsumer Durables Supplies photographic equipment | Consumer Durables |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Raptor Pharmaceutical, Inc.
Raptor Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Glyko, Inc.
Glyko, Inc. Medical SpecialtiesHealth Technology Discovers, develops, and commercializes carbohydrate enzyme therapeutics | Health Technology |
San Francisco State University
San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Mercaptor Discoveries, Inc.
Mercaptor Discoveries, Inc. Pharmaceuticals: MajorHealth Technology Engages in manufacturing drugs | Health Technology |
Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national